Background. Noroviruses (NoVs) represent a considerable public health burden. Despite their enormous genetic diversity, most outbreaks are due to the single GII.4 genotype, but the reasons for this are poorly understood. NoVs use histo-blood group antigens (HBGAs) as attachment factors. Since HBGAs are present in saliva, binding of strains to saliva is commonly used as a surrogate for recognition of the gut surface by specific strains, although the relationship between saliva and gut tissue expression of HBGAs is not well defined.
Noroviruses (NoVs) are the most common cause of acute gastroenteritis, affecting all age groups. Although NoVs cause a self-limited disease that generally lasts 1 or 2 days, the very large number of cases for which they are responsible makes these viruses a considerable public health problem [1] [2] [3] . In addition, NoV gastroenteritis can be severe and life threatening in subjects with a weakened immune system, such as immunocompromised individuals, elderly individuals, and young children [4, 5] . NoVs are small, nonenveloped, positive-sense RNA viruses that present a large genetic diversity. They are classified among 5 genogroups, with strains infecting humans classified in genogroups I (GI), GII, and GIV. Genogroups are further subdivided into genotypes and genotypes into clusters. At least 8 GI and 17 GII genotypes, respectively, were recognized in 2006 for these 2 principal genogroups of human viruses [6] , although this classification is now incomplete due to the increasing number of available sequences, including recombinants [7] . However, during the past 15 years, NoV epidemiology has been largely dominated by a single genotype [8] [9] [10] [11] . Thus, analysis of archival feces samples suggested that, in the 1970s, GII.4 strains might have represented only about 15% of NoV strains in the United States, whereas they are now responsible for 70%-80% of outbreaks worldwide [5] . The reasons for the emergence of such an impressive epidemiological dominance have remained unclear, although 2 main potential nonexclusive mechanisms have been proposed [12] . Changes in catalytic properties of the RNA-dependent RNA polymerase of recent GII.4 strains, including increased activity and error rate, have been suggested to account for a higher replication rate accompanied by a higher ability to evolve immune escape mutants [9] . The second mechanism involves the interaction with attachment factors. GI and GII human strains use carbohydrates of the histo-blood group family (HBGA) as attachment factors [13] . It has been observed that most NoV strains recognize a limited number of these antigens and accordingly infect only subsets of the population, based on the presence of HBGA polymorphisms. The genetic polymorphism of these attachment factors may thus provide herd innate protection, which is akin to herd immunity because individuals not recognized by a given strain fail to transmit the virus, similar to immunized individuals [14, 15] . The large set of HBGA motifs recognized by GII.4 strains allows them to infect a larger spectrum of the human population, compared with other NoV strains, which may provide an advantage in terms of transmission. In addition, pandemic strains reportedly showed increased relative affinity for HBGAs, which might help facilitate escape from blocking antibodies [16] .
Since HBGAs are expressed in saliva, binding of virus-like particles (VLPs) to saliva is often used as a surrogate assay to determine ability of a strain to recognize gut surface glycans [17, 18] . However, the relationship between HBGAs expression in saliva and the stomach or small intestine remains somewhat uncertain, because evidence is based on the study of a limited number of unrelated cases. The present study is primarily aimed at comparing the expression of HBGAs and the binding of VLPs from typical GI and GII strains in a large series of both saliva and stomach biopsy specimens from the same individuals. We observed a number of discrepancies between saliva and tissue HBGA expression with relevance for GII.4 attachment. Unexpectedly, we further observed that these discrepancies were associated with infection with CagA-positive Helicobacter pylori strains.
METHODS

Donors and Samples
All samples were obtained following receipt of informed consent from workers at a shipyard in northern Portugal who participated in a gastric pathology survey during 1998 [19] . Stomach biopsy specimens from the antrum, incisura and corpus, blood samples, and saliva samples were obtained from 109 volunteers. The study accorded with the Declaration of Helsinski and received approval from the Comissão de etica do Hospital de S. João (approval no. 47/2003). Biopsy specimens and blood samples were collected in 1998 and saliva was obtained later, in 2004, during a so-called second-look follow-up survey [20] .
Reagents
Biotin-labeled and peroxidase-labeled UEA-I (Ulex europaeus agglutinin I), specific for H type 2/Le y , were obtained from [17, 23] .
Assay of VLP Attachment to Saliva
VLPs from the GI.1 NV strain and the GII.4 Dijon 1996 strain were produced using a baculovirus expression system and purified by rate-zonal centrifugation in a sucrose gradient, as described elsewhere [24] . VLPs were incubated on saliva samples coated on ELISA plates as described above. Binding of VLPs was detected using polyclonal rabbit anti-GI.1 and anti-GII.4, respectively, followed by incubation with a peroxidase-labeled anti-rabbit immunoglobulins, as previously described [16, 25] .
Immunohistochemical Analysis
Stomach biopsy specimens were formalin fixed and paraffin embedded. Histologic sections (4 μM) were deparaffinized and rehydrated. Sections were then incubated with peroxidase-labeled UEA-I lectin at 4 μg/mL, anti-Le a (CA3F4) at 10 μg/mL, antiLe b (BG6) at 10 μg/mL, anti-SLe x (KM93) at 10 μg/mL, or
VLPs from GI.1 or GII.4 strains at 10 μg/mL each. In the case of primary monoclonal antibodies, binding was detected using secondary peroxidase-labeled anti-mouse immunoglobulin G. VLP binding was detected using anti-GI.1 or anti-GII.4 rabbit antisera, followed by incubation with peroxidase-labeled anti-rabbit immunoglobulin G, and reactions were revealed as previously described. To characterize GII.4 ligand specificity in the case of selected nonsecretor individuals, before incubation with VLP, tissue sections were treated with glycosidases. Screening of the appropriate glycosidases and determination of optimal treatment conditions were performed by ELISA, using saliva from secretor individuals or neoglycoconjugates and then using tissue sections from dog breast carcinoma that express Lewis antigens. Briefly, α(1,2)fucosidase and α(1,3)/α (1,4)fucosidase were first incubated at 10 μg/section and 1 μU/ section, respectively, in 100 mM sodium phosphate ( pH 6.5) for 6 hours at 37°C, followed by a second incubation with fresh enzyme overnight at 37°C. The neuraminidase was used at 0.05 U/section in 50 mM sodium acetate (pH 5.0) in the same conditions as the fucosidases. Control untreated sections were incubated in parallel in the same buffer without glycosidase.
Determination of H. pylori Density and CagA Status
H. pylori density was semiquantitatively scored according to the modified Sydney system that was also used to score glandular atrophy and intestinal metaplasia [26] . Also, H. pylori cagA and vacA genotypes were directly determined in the gastric biopsy specimen from the greater curvature of the antrum by multiplex polymerase chain reaction analysis and reverse hybridization, as previously described [27] .
RESULTS
Relationship Between HBGAs Expression in Saliva and the Stomach Surface Mucosa
A perfect match between secretor saliva phenotypes and FUT2 genotypes was observed for the 109 donors. Eighty-two secretors and 27 nonsecretors (24.7%) were found in the study population. There were 94 Lewis-positive individuals and 15 Lewis negative (13.8%). Among the 94 Lewis positive individuals we observed 2 discrepancies between the serologic phenotypes obtained by classical hemagglutination and by ELISA on saliva. One Le(a+b−) individual was a secretor (FUT2+/−), and 1 Le (a−b+) case was a nonsecretor (FUT2−/−), indicating that the serologic Lewis phenotyping is error prone, as it generated misclassification of the secretor character.
Binding of UEA-I that recognizes α(1,2)-linked fucose residues clearly discriminated secretors and nonsecretors at the saliva level ( Figure 1A ). Since α(1,2)-linked fucose residues are essential for attachment of most NoV strains, we compared saliva expression to the stomach surface mucosa expression of all cases. The surface mucosa of all secretors was strongly or moderately stained by UEA-I, in accordance with the saliva positivity. However, UEA-I binding was also clearly observed in 10 of 27 nonsecretors, indicating that saliva HBGA expression does not always match stomach surface mucosa expression ( Figure 1A and Figure 2 ).
Relationship Between VLP Attachment to Saliva Mucins and to the Stomach Surface Mucosa
We next compared attachment of VLPs to saliva and gastric surface mucosa. Both GI.1 and GII.4 VLPs could distinguish between secretors and nonsecretors at the saliva level. As previously described [28] , saliva samples from B blood group secretors were only weakly recognized by GI.1 VLPs, whereas GII.4 VLPs showed a moderate binding to nonsecretor saliva samples, provided these were Lewis positive. Only the Lewisnegative nonsecretor individuals showed no GII.4 VLP binding to saliva, indicating that the moderate binding to nonsecretor saliva was dependent on the presence of a functional FUT3 allele. At the tissue level, positive staining was obtained with both GI.1 and GII. 4 VLPs for all but 1 tested secretor cases. The single exception was a B blood group case not stained by GI.1 VLP ( Figure 1B) . Among nonsecretors, only 1 of 23 specimens was stained with GI.1 VLP, but 6 of 23 were stained with GII.4 VLP. In the latter case, there was no relationship between the level of saliva binding and the presence of tissue staining.
Since various NoV strains recognize Lewis-type epitopes, we examined the relationship between the presence of Le a and Le b antigens in saliva and at the stomach surface. As shown in Figure 3 is considered a tumor-associated antigen that is not expressed, or only weakly expressed, on the healthy gut epithelium [31] . Interestingly, it was previously reported that SLe x expression could be induced by inflammation and H. pylori infection [32, 33] . Since all cases of our study were infected with H. pylori, we examined SLe x expression at the stomach surface of a subset of cases to examine its possible contribution to GII.4 strains binding to the tissue of nonsecretors. As shown in Figures 2B  and 4A , SLe x expression ranged from strong to negative among secretors, without relationship to H. pylori density (data not shown), whereas all nonsecretors strongly expressed SLe x at the stomach mucosa surface. This is likely due to the absence of competition in nonsecretors between the FUT2 enzyme and the sialyltransferase involved SLe x synthesis. Nevertheless, we observed a clear association between the unexpected UEA-I staining of nonsecretor cases at the tissue level and the binding of GII.4 to the stomach surface mucosa ( Figure 4B ). UEA-I tissue reactivity or GII.4 binding in nonsecretors were not related to H. pylori density, but a relationship was found with the presence of the H. pylori virulence factor CagA. CagA positivity was detected in 55 of 105 tested individuals (52%) in our series. Yet, all nonsecretors who were UEA-I positive and GII.4 binders at the tissue level were infected by CagApositive strains ( Figure 4C and 4D ). Since the presence of the CagA toxin is associated with H. pylori virulence, we looked for possible relationships between UEA-I or GII.4 VLP staining and H. pylori-related pathological signs. We observed strong associations between UEA-I positivity among nonsecretors and the presence of both gastric glandular atrophy and intestinal metaplasia ( Figure 4E and 4F ). Likewise, there were significant associations between the binding of GII.4 VLP to the surface mucosa of nonsecretors and either villus atrophy or the presence of intestinal metaplasia ( Figure 4G and 4H). Glycosidase treatment of the tissue sections was then performed to ascertain the specificity of GII.4 and UEA-I binding to the stomach surface mucosa of nonsecretors infected with 
DISCUSSION
Overall, a rather good concordance was found between expression of HBGAs in saliva and the stomach surface mucosa. This concordance was reflected in the binding of either GI.1 or GII.4 VLPs. Of note, this was not true in the glandular compartment, where HBGAs are expressed regardless of the secretor character and where Le a and Le b antigens are absent. Accordingly, in the glands, staining was observed with both types of VLPs in all individuals (not shown). Since GI.1 and GII.4 infect secretors either exclusively or preferentially [34] [35] [36] , it is clear that HBGA expression in the glandular compartment is irrelevant for infection. It is not clear whether the stomach can be a point of entry of NoVs, but HBGA expression in the stomach and the duodenum are similar [37, 38] . Since small intestinal biopsy specimens are difficult to obtain, we concentrated our attention on the stomach mucosa. Approximately half of adults worldwide are infected with H. pylori, although the incidence greatly varies across populations.
In most developed countries, the prevalence has significantly decreased over the past several decades. It now ranges from 25% to 50% [40, 41] . Yet, it is still high, often >90%, in many countries [40] . In the early 1990s, when this Portuguese study population was sampled, the incidence of H. pylori infection was around 90%, and all individuals in the present study were infected [42] .
CagA is a cytotoxin delivered into the cytoplasm of target cells through the type IV secretion system. It interacts with various proteins involved in cell signaling, thereby causing cellular dysfunctions. Its presence is strongly associated with the development of glandular atrophy, intestinal metaplasia, severe inflammation, and gastric cancer [43] . Over 90% of H. pylori strains isolated in Eastern Asia express CagA, whereas large fractions of strains isolated in Europe and the USA are CagA negative [43, 44] . In our cohort, only 52% of cases were CagA positive, and a recent analysis indicated that as few as 19% of Dutch women infected with H. pylori carried CagA-positive strains [41] . We observed marked associations between the abnormal UEA-I positivity in the surface mucosa from nonsecretors and glandular atrophy, intestinal metaplasia, as well as CagA seropositivity. This strongly suggests that CagA-positive H. pylori strains induce expression of FUT1 in the surface gastric epithelial cells, generating binding sites for GII.4 strains, even in the absence of a functional FUT2 allele. Because infection with CagA-positive H. pylori is strongly associated with the presence of intestinal metaplasia, intestinal metaplasia may serve as a point of entry for the virus.
Individuals who are not susceptible to infection with a given NoV strain are similar to immunized individuals since they do not support transmission of the virus. The polymorphism of HBGAs therefore restricts the circulation of NoVs in a manner akin to herd immunity. For this reason, we have called this phenomenon herd innate protection [15] . GII.4 strains that have the ability to recognize the broadest range of HBGAs are at an advantage in this respect because it gives them a high host range, providing an increased ability to circulate as compared to other strains. We have seen here that the host range of GII.4 strains can be further expanded owing to another common gut pathogen responsible for chronic infections. In populations where most individuals, with the exception of young children, are infected with H. pylori strains expressing the CagA virulence factor, restriction of transmission of GII.4 strains by the genetic polymorphisms of FUT2 and, possibly, FUT3 can be bypassed. Therefore, our observations suggest that CagApositive H. pylori infection contributed to generate and maintain the epidemiological dominance of GII.4 strains once they acquired the ability to bind to a large array of HBGA motifs, including A, B, H, Lewis y, Lewis b, and sialyl-Lewis x. Reducing the incidence of H. pylori infection, particularly in countries where it is high and mainly involves CagA-positive strains, could therefore indirectly contribute to a significant reduction in the incidence of NoV infection, as well.
Notes
